WinstonWınston
Back
Guardian Pharmacy Services logo

Guardian Pharmacy Services

GRDN
56
Medical - Care Facilities · Healthcare
Price
$37.93
+0.45 (+1.20%)
Market Cap
$2.40B
Winston Score
56
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Strong
Stability
Exceptional
Valuation
Mixed

Share count rising — dilution

+4.0% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 60.8M (2021) → 63.3M (2025)

Winston Score History

The full picture

Guardian Pharmacy Services delivers prescription medications and pharmacy services to people living in long-term care facilities, such as nursing homes and assisted living communities. Instead of patients going to a regular pharmacy, Guardian brings the medications directly to these facilities and manages the entire dispensing process. The company operates as a specialty pharmacy focused almost entirely on the long-term care market across the United States.

Guardian makes money by dispensing medications and charging for the pharmacy management services it provides to care facilities. It operates a network of local pharmacy locations spread across multiple states, allowing it to serve facilities with fast, reliable delivery — a key advantage that is hard for large national chains to replicate at the local level. The main growth driver is the aging U.S. population, which is steadily increasing demand for long-term care beds and the pharmacy services that support them, though reimbursement rate pressure from Medicare and Medicaid remains an ongoing risk to profit margins.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+2.2% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+133.3% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

19.3%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$90M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Guardian Pharmacy Services is growing revenue at 2% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
22.8%
Thin — 22.8% gross margin
Profit after running costs
Operating Margin
5.9%
Thin — 5.9% operating margin
Return on the money invested
ROCE
34.6%
Exceptional — 34.6% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+10.3%
Steady sales growth (+10.3% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
159%
Turns 159% of profit into real cash
Spare cash per sale
FCF Margin
5.5%
Thin free cash flow (5.5%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.03
Conservative — low debt load (0.03)
Covers its interest
Interest Cover
145.39x
Comfortably covers interest (145.4x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
36.1x
Pricey — P/E 36.1

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+1.3
GROWING
Earnings expected to grow — slightly cheaper on forward P/E

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial